ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MHRA authorises Amarin’s heart drug Vazkepa pharmatimes
April 23, 2021Amarin’s Vazkepa has received authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) as a treatment to reduce the risk of cardiovascular (CV) events in high-risk patients. -
Kesimpta and Vazkepa among latest CHMP recommendations pharmatimes
February 01, 2021The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended 13 new medicines for approval in its latest meeting.
Pharma Sources Insight January 2025
